Skip to main content
CareRay Digital Medical Technology Co., Ltd. logo

CareRay Digital Medical Technology Co., Ltd. — Investor Relations & Filings

Ticker · 688607 ISIN · CNE100004BR9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 575 across all filing types
Latest filing 2026-05-24 Director's Dealing
Country CN China
Listing Shanghai Stock Exchange 688607

About CareRay Digital Medical Technology Co., Ltd.

http://www.careray.cn/

CareRay Digital Medical Technology Co., Ltd. specializes in the research, development, and manufacturing of advanced digital X-ray flat panel detectors. The company provides a comprehensive portfolio of imaging solutions, including amorphous silicon (a-Si) and IGZO-based detectors designed for medical, veterinary, and industrial applications. Its core technological strengths lie in high-performance scintillator deposition and low-dose imaging algorithms, ensuring superior image quality and diagnostic precision. CareRay serves a global market, offering both wireless and tethered detectors that integrate seamlessly into radiography, fluoroscopy, and mammography systems. By focusing on continuous innovation in sensor technology and hardware-software integration, the company delivers reliable, high-resolution digital imaging components to original equipment manufacturers and healthcare providers worldwide.

Recent filings

Filing Released Lang Actions
康众医疗股东减持股份计划公告
Director's Dealing Classification · 92% confidence The document is an announcement by a controlling shareholder and director (高鹏) of the planned reduction (sale) of his personal holdings in the company, detailing the number of shares to be sold, time period, methods (centralized bidding and block trades), lock-up commitments, and regulatory compliance. This corresponds to insiders’ share transactions (director/shareholder dealing), not a company share buyback, financial report, or dividend notice. Hence it should be classified as Director’s Dealing (DIRS).
2026-05-24 Chinese
康众医疗2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the resolutions passed at the company’s 2025 Annual General Meeting, detailing each proposal voted on and the voting results. It does not contain the underlying reports themselves but declares shareholder voting outcomes. This corresponds to the “Declaration of Voting Results & Voting Rights Announcements” category.
2026-05-15 Chinese
北京市中伦律师事务所关于江苏康众数字医疗科技股份有限公司2025年年度股东会的法律意见书
Regulatory Filings Classification · 90% confidence The document is a legal opinion letter (法律意见书) by Zhong Lun law firm on the convening, procedures, voting, and results of the 2025 annual shareholders’ meeting of Jiangsu Kangzhong Digital Medical Technology Co., Ltd. It is not the notice or minutes of the AGM itself, nor is it the company’s presentation, proxy statement, or standalone vote-results announcement. It is an external counsel’s compliance/legal opinion, which falls under general regulatory filings (RNS) as a compliance/legal document rather than any specialized category.
2026-05-15 Chinese
康众医疗2025年年度股东会会议资料
Regulatory Filings
2026-05-07 Chinese
康众医疗关于参加“十五五·科创惠民——科创板企业成果转化与民生赋能之2025年度医疗器械行业集体业绩说明会”的公告
Regulatory Filings
2026-05-07 Chinese
中信证券股份有限公司关于江苏康众数字医疗科技股份有限公司使用节余募集资金永久补充流动资金的核查意见
Capital/Financing Update Classification · 95% confidence The document is a formal opinion from a sponsor (中信证券股份有限公司) regarding the use of surplus raised funds by 江苏康众数字医疗科技股份有限公司. It details the background of the fundraising, the amount raised, the use of funds, the surplus generated from interest and financial management, and the company's decision to permanently supplement working capital with the surplus. The document includes references to regulatory compliance, board approvals, and audit verification. It is not a full financial report, earnings release, or annual/interim report. It is a regulatory compliance and verification statement related to capital use, specifically about the use of surplus raised funds. This fits best under the category of Capital/Financing Update (CAP), as it concerns updates on the use of fundraising proceeds and capital structure changes. The document length is 2228 characters, which is substantive for such an opinion but not a full report. Therefore, the classification is CAP with high confidence.
2026-04-24 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.